Zykadia was 1st FDA win for Novartis in San Diego
This article was originally published in Scrip
Executive Summary
The Genomics Institute of the Novartis Research Foundation (GNF) in San Diego reached a major milestone in April with US FDA approval for the lung cancer drug Zykadia (ceritinib), because it was the first FDA approval for a compound discovered at GNF.